| Authors: |
Dawson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huntly BJP; University of Cambridge, Cambridge, United Kingdom., Karadimitris A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Alegre A; Hospital Universitario de La Princesa and Quironsalud, Madrid, Spain., Chaidos A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Pollyea DA; University of Colorado School of Medicine, Aurora, Colorado., Davies FE; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Morgan GJ; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Glass JL; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Kamdar M; University of Colorado School of Medicine, Aurora, Colorado., Mateos MV; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain., Tovar N; Hospital Clínic, University of Barcelona, Barcelona, Spain., Yeh P; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Delgado RG; Hospital Virgen de la Victoria, Málaga, Spain., Basheer F; Addenbrooke's Hospital, Cambridge, United Kingdom., Marando L; University of Cambridge, Cambridge, United Kingdom., Gallipoli P; Addenbrooke's Hospital, Cambridge, United Kingdom., Wyce A; GSK, Collegeville, Pennsylvania., Krishnatry AS; GSK, Collegeville, Pennsylvania., Barbash O; GSK, Collegeville, Pennsylvania., Bakirtzi E; GSK, Collegeville, Pennsylvania., Ferron-Brady G; GSK, Collegeville, Pennsylvania., Karpinich NO; GSK, Collegeville, Pennsylvania., McCabe MT; GSK, Collegeville, Pennsylvania., Foley SW; GSK, Collegeville, Pennsylvania., Horner T; GSK, Collegeville, Pennsylvania., Dhar A; GSK, Collegeville, Pennsylvania., Kremer BE; GSK, Collegeville, Pennsylvania., Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. |
